Viewing Study NCT00024557

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2025-12-30 @ 7:18 AM
Study NCT ID: NCT00024557
Status: COMPLETED
Last Update Posted: 2011-06-06
First Post: 2001-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Sponsor: INSYS Therapeutics Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
None Glioblastoma Multiforme View
None Anaplastic Astrocytoma View
None Mixed Oligoastrocytoma View
None Malignant Astrocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neurosurgery, craniotomy View
None convection-enhanced delivery View
None CNS interstitial infusion View
None recombinant toxins View
None malignant glioma, recurrent View
None intratumoral therapy View
None positive pressure microinfusion View